Search Results (366)

Persistent organic contaminants and complex wastewater matrices challenge conventional treatment because parent-compound removal does not necessarily imply mineralization, detoxification, or improved environmental safety. Advanced oxidation processes can address these limitations, but practical effectiveness is often constrained by oxidant activation, gas–liquid mass transfer, reagent distribution, light penetration, catalyst contact, energy demand, and matrix scavenging. This work critically examines hydrodynamic cavitation-assisted advanced oxidation processes for water and wastewater treatment, including systems based on hydrogen peroxide, ozone, Fenton and Fenton-like reactions, persulfate, peroxydisulfate, peroxymonosulfate, UV irradiation, photocatalysis, cold plasma, multi-hybrid configurations, and emerging reduction-oriented approaches. The discussion covers reactor configurations, target contaminants, real matrices, and sustainability-related performance metrics. The central argument is that hydrodynamic cavitation is not automatically sustainable as a stand-alone treatment. It becomes relevant as a sustainable intensification module only when measurable improvements are demonstrated in oxidant activation, mass transfer, treatment depth, biodegradability, toxicity reduction, process integration, or scale-up at acceptable energy and chemical cost. A reporting framework is proposed based on mineralization, COD/TOC reduction, by-products, toxicity, biodegradability, normalized energy consumption, chemical efficiency, real-matrix validation, reproducibility, and cost-relevant indicators. Future progress should move from isolated degradation tests to integrated, controllable, and scalable treatment frameworks. Full article

Plant-derived bioactive compounds, such as polyphenols and saponins, possess significant pharmacological value. However, conventional extraction methods often suffer from low efficiency, poor bioavailability, and environmental burdens. Aspergillus-based biotransformation has emerged as a superior platform for overcoming these limitations due to their robust secretomes, versatile metabolic networks, and the GRAS (Generally Recognized as Safe) status of specific industrially relevant species (e.g., A. oryzae and A. niger). Existing literature frequently focuses on isolated compounds or general fungal processes. To fill this gap, this review systematically links specific Aspergillus enzymatic systems to an “enzymatic hydrolysis–transformation–synthesis” closed-loop framework, which is essential for industrial-scale valorization. In this review, we summarize recent advances in the biotransformation of phytochemicals by A. niger, A. oryzae, and A. nidulans. These fungi utilize specialized enzymes—including β-glucosidases, cellulases, and glycosidases—to enable precise hydrolysis, deglycosylation, and detoxification under mild conditions. We highlight representative transformations that demonstrate markedly enhanced bioactivity and solubility. Key examples include the conversion of polydatin to resveratrol (>90% yield) and ginsenoside Rb1 to ginsenoside compound K (94.4% conversion rate). Although industrial applications span the food, pharmaceutical, and cosmetic sectors, significant challenges persist in solid-state fermentation (SSF) scale-up, strain stability, target compound over-degradation, and downstream purification. Genetic engineering, process optimization and hybrid bioprocessing are highlighted as promising strategies to overcome these limitations and realize sustainable, high-value production of natural bioactive metabolites. Full article

Sports nutrition products are increasingly expected to deliver bioactive compounds that aid in recovery, reduce fatigue, and support physiological regulation, going beyond merely providing energy and nutrients. However, many bioactive compounds face challenges such as poor aqueous dispersibility, limited stability, low bioaccessibility, or inefficient absorption, which hinder their practical use in real food products. This review critically examines food-grade, gel-based delivery systems for bioactive compounds in sports nutrition from a design-driven perspective. It focuses on hydrogels, microgels, emulsion gels, protein gel matrices, and multicomponent gel architectures that prioritize structural stability, digestion-triggered responsiveness, and compatibility with food. Key design principles are discussed, including the need to maintain stability during processing and storage, balance protection with release, and tailor delivery structures to sports-specific constraints such as gastrointestinal tolerance, osmotic load, nutrient timing, and changes in digestion related to exercise. The review also analyzes the effectiveness of gel-based and hybrid systems in liquid, solid, and semi-solid sports nutrition products, emphasizing how the product format and consumption scenario can influence delivery performance. A design decision framework is proposed to align bioactive properties, food format, target release profile, and exercise-stage requirements with appropriate delivery architectures. Current challenges are also addressed, including difficulties in predicting structure–function relationships, limited robustness during scale-up processes, and inadequate functional evaluation. Overall, gel-based food delivery systems provide a promising solution for improving the stability, release behavior, and practical functionality of bioactives in sports nutrition. Full article

The mitigation of anthropogenic climate change caused by fossil fuel combustion is a critical global challenge that necessitates a transition to renewable energy systems. Bioethanol represents a major renewable fuel, but first-generation production relies on edible feedstocks, which raises concerns regarding food security. Consequently, research is shifting toward second-generation bioethanol produced from abundant non-edible lignocellulosic biomass sources. This review comprehensively examines the potential of Candida krusei (synonyms: Pichia kudriavzevii, Issatchenkia orientalis) to serve as an alternative biocatalyst for second-generation bioethanol production. Compared with the first-generation bioethanol-producing yeast Saccharomyces cerevisiae, C. krusei exhibits superior physiological traits, such as thermo, acid, and inhibitor tolerances, enabling the utilization of several lignocellulosic feedstocks. This review summarizes the taxonomic and physiological characteristics of C. krusei, describes case studies on bioethanol production, and discusses strategies for reducing production costs. Furthermore, the technical and biosafety challenges associated with the industrial deployment of C. krusei are critically examined, including xylose metabolism limitations, scale-up constraints, and the management of its opportunistic pathogenic nature. A life cycle assessment perspective suggests that the unique physiological properties of C. krusei contribute to reducing greenhouse gas emissions and energy consumption throughout the entire production process, from pretreatment to downstream ethanol recovery. Full article

Glycosylation is a critical structural modification that shapes the pharmacological properties of bioactive ingredients from Traditional Chinese Medicine (TCM), and UDP-glycosyltransferases (UGTs) are the core rate-limiting biocatalysts mediating this process. Traditional plant extraction methods are constrained by resource scarcity, long growth cycles, low target content and high environmental costs, which cannot meet the large-scale industrial demand for high-value medicinal glycosides. This review systematically outlines the latest global advances in medicinal plant UGT research, covering family classification and physiological functions, multi-omics and AI-assisted gene mining, molecular basis of substrate recognition and catalytic specificity, protein engineering for performance optimization, and the construction of full-spectrum biomanufacturing systems including in vitro multi-enzyme cascades, microbial cell factories and plant suspension cell cultures. We further discuss the core challenges of industrial scale-up, regulatory compliance and clinical translation, as well as the significant economic and technical advantages of synthetic biology-based UGT biomanufacturing platforms. This work provides a complete technical framework for the engineering application of medicinal plant UGTs, to support the green and scalable production of rare natural therapeutic glycosides. Full article

The growing demand for sustainable food packaging has intensified interest in biodegradable materials that can reduce environmental impact while preserving food quality. Among these materials, biodegradable polyester–starch composite films functionalized with phenolic compounds have gained attention as promising active packaging systems. They combine the melt processability and structural stability of polyesters, such as poly(lactic acid) (PLA), poly(butylene adipate-co-terephthalate) (PBAT), poly(butylene succinate) (PBS), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) with the renewability and biodegradability of starch and the antioxidant, antimicrobial, and UV-protective functions of phenolics, such as ferulic acid, quercetin, tea polyphenols, and anthocyanins. This review discusses recent advances in the selection of biodegradable polyesters, starch and thermoplastic starch blending, phenolic incorporation strategies, and their effects on compatibility, morphology, mechanical strength, barrier properties, optical behavior, release, and active packaging functionality. The characteristics and functionality of these films are governed not only by the individual components but also by phase morphology, interfacial interactions, phenolic location, processing conditions, and release control. Key challenges include polyester–starch incompatibility, TPS moisture sensitivity, phenolic stability during melt processing, migration safety, controlled release, and industrial scale-up. Collectively, biodegradable polyester–starch films functionalized with phenolic compounds represent a promising route for developing next-generation sustainable active packaging and may contribute to circular economy approaches. Full article

Microplastic pollution has become a significant environmental concern due to its persistence and widespread impact across ecosystems. These plastic particles (1 μm to 5 mm), originating from larger plastic debris or industrial sources, accumulate in diverse habitats, affecting biodiversity and human health. Microplastics resist natural degradation, posing challenges to both ecological sustainability and waste management strategies. Although numerous studies have explored microbial degradation, most existing research focuses primarily on bacteria, leaving the role of filamentous fungi comparatively underexplored. This represents a significant research gap, because fungi secrete a variety of extracellular enzymes, including laccases, peroxidases, and esterases, which play crucial roles in the breakdown of synthetic polymers. These enzymes facilitate the depolymerization of microplastics by targeting polymer chains and increasing their susceptibility to further microbial degradation. However, the underlying enzymatic mechanisms and their effectiveness in microplastic remediation remain insufficiently characterized. Here, we critically review the potential of filamentous fungi for microplastic biodegradation, emphasizing their oxidative and hydrolytic enzyme systems, biosurfactant production, and mechanisms of adsorption and mineralization. The novelty of this review lies in consolidating the most recent mechanistic insights into fungal-driven depolymerization pathways, integrating them with advances in genetic engineering, bioprocess scale-up, and regulatory perspectives, areas rarely combined in previous reviews. We identify current limitations related to environmental applicability, enzyme accessibility, and the lack of standardized protocols, and propose strategies to overcome these challenges through enzyme immobilization, microbial consortia design, and synthetic biology approaches. By addressing these gaps, filamentous fungi may contribute to the development of sustainable strategies for plastic pollution mitigation and support circular economy approaches toward polymer biodegradation. Full article

Paclitaxel (Taxol), a taxane diterpenoid from Taxus species, is a clinically important microtubule-stabilizing anticancer agent widely used in chemotherapy. However, its supply remains limited by precursor scarcity and the molecule’s structural complexity. The biosynthetic pathway from geranylgeranyl diphosphate (GGPP) to paclitaxel is estimated to involve 19 to 23 enzymatic steps. Recent multi-omics approaches have substantially elucidated this pathway, yet key mechanistic questions persist, notably the formation of the oxetane ring. Complete heterologous biosynthesis is further hampered by poor cytochrome P450 (CYP) expression in non-native hosts and insufficient metabolic flux. This review synthesizes advances across four themes: (1) progressive elucidation of the biosynthetic pathway, with emphasis on the CYP-mediated oxygenation cascade and oxetane ring formation; (2) genomic and regulatory insights from Taxus genome assemblies, transcription factor networks, and spatial multi-omics; (3) metabolic engineering in microbial hosts, including Escherichia coli, Saccharomyces cerevisiae, and non-conventional chassis; and (4) plant-based heterologous production platforms. Critical bottlenecks are identified, including unresolved enzymatic steps, CYP functional expression, flux partitioning, and bioprocess scale-up. Strategies to overcome these challenges are discussed. Full article

Reactive polymeric membranes are emerging as promising platforms for advanced water and wastewater treatment because they combine separation with in situ contaminant transformation. Unlike conventional membranes, which mainly retain pollutants, reactive polymeric membranes can enrich, activate, and degrade micropollutants during permeation through built-in radical, redox-active, conductive, or porous catalytic domains. This review discusses the development of intrinsic reactive polymer membranes for oxidative filtration, with emphasis on the links between polymer structure, transport behavior, reactive oxygen species generation, and degradation pathways. Key membrane classes are discussed, including stable-radical polymers, redox-active polymer networks, conductive polymer membranes, and porous conjugated polymer catalytic layers. The review also highlights the importance of reactive transport kinetics, including convection–diffusion–reaction coupling, residence time, Damköhler and Péclet numbers, and adsorption-enhanced degradation. Challenges such as fouling, polymer aging, leaching, byproduct formation, and toxicity-aware benchmarking are discussed within a broader roadmap for technology translation. The review identifies the grand challenges and milestone-based priorities for developing and deploying reactive polymer membranes, including performance targets, standardized reporting, realistic water matrices, scale-up, technology readiness levels, techno-economic analysis, life cycle assessment, artificial intelligence, and digital twins. Together, these elements guide the translation of reactive polymer membrane systems from laboratory research toward full-scale water treatment applications. Full article

Postbiotics are increasingly recognized as a predominant group of biotherapeutic agents sourced from the microbial secretome, offering functional benefits, while circumventing the safety concerns associated with the application of live microbial consortia. These microbial derivatives are emerging as promising approaches for tackling complex diseases, encompassing cancer, autoimmune diseases, and metabolic disorders, through modulation of host cell signalling pathways, including G protein-coupled receptors (GPCRs), the NF-κB (Nuclear Factor Kappa B) pathway, and epigenetic regulatory pathways. Besides systemic effects, postbiotics may also have localized effects, such as epithelial regeneration, modulation of fibroblast functions, and control of collagen remodelling. Eventually, the scale-up in the production of postbiotics has initiated new avenues in improving sustainable agriculture and environmental biotechnology. This comprehensive review attempts to integrate mechanistic insights and translational applications, highlighting the therapeutic potential of postbiotics across biomedical and ecological domains. These observations could pave the way to bridge the gap between microbiome regulation, precision medicine, and sustainable biotechnology, thereby positioning postbiotics as a versatile tool addressing some of the most pressing health and sustainability challenges of the 21st century. Full article

Background/Objectives: Despite ongoing innovation, few interventions—including Clinical Decision Support Systems (CDSS)—are successfully integrated into routine care. Understanding the process through which innovations are implemented is therefore essential for advancing practice and research. In perinatal settings, evidence on how CDSS implementation unfolds and which strategies support adoption, scale-up, and sustainment remains limited. This study aimed to understand the implementation process, key determinants and implementation strategies of a shared antenatal psychosocial CDSS (i.e., the Born in Belgium Professionals [BIB-Pro]) implemented in a real-world, cross-sectoral perinatal care setting. Methods: A qualitative exploratory case study was conducted between January and March 2025. Data included semi-structured interviews with all seven implementation agents, document analysis of the implementation plan. Directed content analysis was applied using the Exploration, Preparation, Implementation, Sustainment (EPIS) framework to categorise contextual determinants and the ERIC taxonomy to classify implementation strategies. Data were synthesised across the four EPIS phases. Results: The implementation process unfolded across all EPIS phases, showing a shift in responsibility from the policy level to the implementation team and healthcare organisations. Implementation was shaped by key determinants across multiple levels: (1) the bridging functions by the BIB-Pro implementation agents connecting policy, innovation, and organisational practice; (2) the system-level leadership and funding by the National Institute for Health and Disability Insurance that enabled initiation and sustainability; and (3) the multilevel stakeholder involvement and inter-organisational collaboration across care settings. In addition, the personal attributes of implementation agents—accessibility, active listening, adaptability, and persistent follow-up—were also identified as relevant factors in the implementation process. Across the implementation process, a broad range of implementation strategies was identified. The most prominent ERIC strategies were developing stakeholder interrelationships, evaluative and iterative strategies, engaging stakeholders, training and educating stakeholders, and providing interactive assistance. Barriers encountered during the implementation process included fragmented care networks, inconsistent regional referral structures, legal uncertainties, and variable digital readiness. In response to these challenges, implementation strategies were applied to support collaboration, clarify procedures and provide targeted support. Conclusions: This study provides insight into how a CDSS was introduced, scaled, and sustained across complex multiple Belgian perinatal care settings. Strong bridging functions, stakeholder interrelationships, iterative evaluation, and system-level support were key factors throughout the implementation process. Across all phases, stakeholder interrelationship strategies and evaluative and iterative strategies were the most prominent and consistently applied, supporting stakeholder engagement and sustained use of the platform. These findings offer actionable guidance for implementing digital tools in multi-organisational and multi-level contexts within perinatal care and other healthcare settings. Full article

This review synthesizes current advances in the biocatalytic upcycling of plastic waste through microbial and enzymatic systems, emphasizing the transformation of recalcitrant polymers into high-value products. A narrative review methodology was adopted to integrate interdisciplinary findings across microbiology, enzymology, biotechnology, and waste management. Significant progress has been achieved in the depolymerization of plastics such as polyethylene terephthalate (PET), polyurethane, and polyolefins into intermediates, including terephthalic acid and ethylene glycol. These intermediates are subsequently valorized into products such as polyhydroxyalkanoates (PHAs), lipids, terpenoids, organic acids, aromatic compounds, and bacterial cellulose. Quantitative performance metrics demonstrate the potential of these systems. Notably, PHA production from PET-derived substrates has reached up to 1.10 g L⁻¹ (22.7% cell dry weight) and as high as 46% intracellular accumulation, while bacterial cellulose production from PET hydrolysates has achieved ~3.0 g L⁻¹. High conversion efficiencies have been reported in several pathways, including ~90–99% conversion of PET-derived intermediates to catechol, ~91.6% yield of glycolic acid from ethylene glycol (up to 31.4 g L⁻¹), and ~71–79% molar conversion of terephthalic acid to vanillin. Despite these advances, critical limitations persist, including low volumetric productivity in some systems, metabolic imbalances, substrate toxicity, feedstock heterogeneity, and challenges in process integration and scale-up. Future research should prioritize enhancing metabolic flux, improving enzyme efficiency, optimizing microbial consortia, and developing integrated, low-energy depolymerization–bioconversion systems. Full article

The removal of persistent pharmaceutical compounds such as carbamazepine (CBZ) by advanced oxidation processes (AOPs) remains a major challenge in water treatment, particularly in relation to understanding the operating conditions governing reaction kinetics and transformation pathways. In this context, this study aims to evaluate the effect of ozone concentration on the kinetics and mechanistic regimes of CBZ ozonation in aqueous solutions. Ozonation experiments were conducted in an aqueous solution at an initial CBZ concentration of 50.0 mg/L, using inlet ozone concentrations between 1.9 and 58.5 g/m³ under controlled conditions. CBZ degradation followed apparent pseudo-first-order kinetics under the studied conditions, with the corresponding apparent rate constant increasing linearly with the inlet ozone concentration. At ozone concentrations ≥ 15.7 g/m³, rapid CBZ removal was observed, together with high dissolved ozone levels, accelerated loss of aromaticity, and transient formation of colored oxidation intermediates, which were subsequently degraded. In contrast, low ozone concentrations led to ozone-limited kinetics and slower aromatic breakdown. The pH evolution revealed two distinct kinetic regimes, transitioning from oxidant-limited to reaction-controlled behaviour and stabilizing at pH 4.3. These findings may provide guidelines for optimizing ozone-based treatment processes. The insights gained may be applied to the design, scale-up, and operation of advanced and hybrid oxidation systems. Full article

The need for the rapid advancement of lithium-based energy storage technologies continues to outpace progress in materials development and manufacturing, creating a widening gap between laboratory-scale innovation and industrial deployment. There is a need to examine the key materials and processing challenges that limit the performance, cost-effectiveness, and sustainability of next-generation lithium batteries. For material considerations, many commonly used electrodes face issues of volumetric expansion and performance degradation over charging cycles. To address these issues, binders are a crucial component to consider as they adhere active materials to the electrodes, and their structure can be altered to mitigate undesirable effects from these components. Hence, the selection and exploration of alternative binders are becoming increasingly important in the pursuit of longer-lasting and safer Li-batteries. From a manufacturing perspective, current production lines rely on multistep, energy-intensive processes, e.g., from slurry-mixing to cell assembly, that elevate costs and complicate scale-up. Emerging chemistries incorporating nanomaterials or solid-state components face additional barriers related to yield, process control, and defect management, all of which can exacerbate safety risks related to processing during production and thermal runaway in produced batteries. End-of-life considerations, including disassembly, recycling, and the safe handling of toxic materials, further contribute to the technological and logistical complexity of large-scale deployment. The field is moving toward sustainable material alternatives, more efficient and adaptive manufacturing routes, and advanced technologies such as solid-state electrolytes and nanostructured electrodes. Together, these developments provide a roadmap for overcoming current bottlenecks and enabling the next generation of high-performance, safe, and sustainable lithium battery technologies. This review examines the progress made in finding alternative materials and synthesis methods for the optimization of lithium battery cells, with a focus on the development of novel binders, slurry synthesis and manufacturing framework. In addition, the advantages and limitations of the alternative binder materials and processes are also explored, with a focus on scalability for manufacturing, safety concerns, sustainability and end-of-life challenges. Full article

People suffering from gout and hyperuricemia have limited consumption of soy products because of their high purine content, even though soybean is a nutrient-rich crop. This study developed a combined purine reduction process: ultrasonic-assisted soaking to promote purine dissolution and isoelectric point precipitation to separate purines with minimal protein loss. A high-performance liquid chromatography (HPLC) method for rapid purine determination was first established (R² > 0.9999, RSD < 0.23%), thereby providing technical support for process optimization. Using soybean powder as the raw material, optimal ultrasonic conditions (58 °C, 250 W, 58 min) were identified, achieving a purine removal rate of 61.15% with a protein recovery of 94.23%. Scanning electron microscopy (SEM) and Fourier-transform infrared (FTIR) spectroscopy analyses revealed that ultrasonic treatment altered the microstructure of the soybean powder, thereby facilitating purine dissolution. Low-purine soymilk prepared from the resulting soybean powder exhibited a unique flavor, with enhanced electronic nose response signals of its flavor compounds. This process effectively reduces purine content while preserving soy protein and flavor, offering a feasible technical solution for the development and industrial application of low-purine soy products. However, challenges remain in process scale-up and in optimizing the balance between purine removal and nutrient retention. Full article